2021
DOI: 10.1038/s41533-021-00236-w
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary function testing in COPD: looking beyond the curtain of FEV1

Abstract: Chronic obstructive pulmonary disease (COPD) management remains challenging due to the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the disease. Airflow limitation, diagnosed by spirometry, remains the cornerstone of the diagnosis. However, the calculation of the forced expiratory volume in the first second (FEV1) alone, has limitations in uncovering the underlying complexity of the disease. Incorporating additional pulmonary function tests (PFTs) in the everyday clinical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
26
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(26 citation statements)
references
References 155 publications
0
26
0
Order By: Relevance
“…Studies have shown that COPD patients with higher mMRC scores have higher emergency room and hospitalization rates, and that mMRC ≥ grade two in COPD patients is associated with higher healthcare and social costs [ 26 ]. Pulmonary function testing is a tool for diagnosing the degree of airflow obstruction in COPD [ 28 ], but FEV1 is not sufficient to measure the overall severity of COPD. However, FEV1 remains a useful reference for physicians to assess clinical severity or treatment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Studies have shown that COPD patients with higher mMRC scores have higher emergency room and hospitalization rates, and that mMRC ≥ grade two in COPD patients is associated with higher healthcare and social costs [ 26 ]. Pulmonary function testing is a tool for diagnosing the degree of airflow obstruction in COPD [ 28 ], but FEV1 is not sufficient to measure the overall severity of COPD. However, FEV1 remains a useful reference for physicians to assess clinical severity or treatment.…”
Section: Discussionmentioning
confidence: 99%
“…However, FEV1 remains a useful reference for physicians to assess clinical severity or treatment. In particular, decreased FEV1 was associated with exacerbation frequency [ 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…Its good quality is influenced by a variety of factors, including subjects’ cooperation, sophisticated technologist, and precise instrumentation ( Culver et al, 2017 ). Sotirios ( Kakavas et al, 2021 ) et al believed that the calculation of the FEV 1 alone has limitations in detecting the underlying complexity of COPD disease. Our study also found that compared to the pulmonary function test, preoperative PaO 2 is a more objective and reliable parameter to evaluate the risk of postoperative respiratory failure in COPD patients.…”
Section: Discussionmentioning
confidence: 99%
“…Compared to COPD patients with pulmonary function in GOLD IV category, patients in GOLD I (OR=0.175, 95% CI=0.035–0.869, P =0.033) and GOLD II (OR=0.177, 95% CI=0.044–0.712, P= 0.015) were less likely to be in the “good health group“; compared to the “good health group”, COPD patients in Gold II (OR=0.217, 95% CI=0.063–0.754, P =0.016) category were also less likely to be in the “health low-level group”, suggesting that COPD patients in high Gold category reflect low levels of health, in line with the results of Ragland et al 27 Pulmonary function, as the gold standard for the assessment of COPD patients’ condition, reflects the severity of their condition. 36 It has been shown by some research studies that self-monitoring of respiration can help identify illness changes in their condition early. 37 Therefore, caregivers should pay attention to patients with poor pulmonary function and encourage them to pay close attention to their own airway function, as well as review their pulmonary function regularly to improve their quality of life.…”
Section: Discussionmentioning
confidence: 99%